Biologics Are Effective in the Management of Inflammatory Bowel Disease Following Liver Transplantation in Combination With Antirejection Therapy

Inflamm Bowel Dis. 2022 Dec 1;28(12):e150-e152. doi: 10.1093/ibd/izac207.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biological Factors
  • Biological Products* / therapeutic use
  • Humans
  • Immunosuppression Therapy
  • Inflammatory Bowel Diseases* / drug therapy
  • Liver Transplantation*

Substances

  • Biological Products
  • Biological Factors